JackFrost25
$PGEN $INO What does that say about Inovio management that they didn't collect durability data prospectively and now cannot use it in promoting the drug?. 5 patients used alternative treatments in Year 2 and 4 were lost to follow-up. Trash. It is academic at this point. Inovio cannot utilize Year 2 data in promotional materials and sales reps cannot discuss it with surgeons. 5 year Papzimeos durability data vs. 1 year Voceryq durability data. That is all that matters in the real world. Game over.
2
7

:format(webp)/https%3A%2F%2Fstaticx-tuner.zacks.com%2Fimages%2Fdefault_article_images%2Fdefault28.jpg)
:format(webp)/https%3A%2F%2Fstaticx-tuner.zacks.com%2Fimages%2Farticles%2Fmain%2F2c%2F285.jpg)